Infosys-Backed 4baseCare Raises Rs 128 Crore to Expand Global Cancer Testing Platform
Precision oncology startup 4baseCare has raised Rs 128 crore to expand its genomics laboratories globally and scale its AI-driven oncology platform, OncoTwin. Backed by Infosys and growX Ventures, the Bengaluru-based company aims to make precision oncology more inclusive for under-represented populations across India, the Middle East, Southeast Asia, and Latin America. Founded in 2019, 4baseCare operates labs in India, Dubai, Nepal, and the Philippines, with plans to enter 8-10 more countries and decentralize genomic testing infrastructure in India.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is positive (75/100). Lens Score 40/100 — moderate-to-low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- economictimes— balanced framing, positive sentiment
- economictimes— balanced framing, positive sentiment
AI Analysis
The articles present a business and technology-focused perspective without political framing. They highlight investment and expansion plans of a precision oncology startup, emphasizing innovation and inclusivity in healthcare. The coverage includes statements from company founders and investors, reflecting a neutral, growth-oriented viewpoint without partisan or ideological bias.
The tone across the articles is positive and optimistic, focusing on the startup's successful fundraising and plans for global expansion. The coverage highlights advancements in cancer diagnostics and AI technology, portraying progress and potential benefits for under-represented populations. There is no critical or negative sentiment present.
How 2 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.